Nanotrap® Microbiome A Particles 10 mL

Labs around the world are using Nanotrap® Microbiome Particles to capture and concentrate microbes from samples in order to improve detection of those microbes.

The Nanotrap Microbiome A Particles have been demonstrated to capture and concentrate a wide range of microbes, including: influenza A virus, influenza B virus, respiratory syncytial virus, coronavirus 229E, coronavirus OC43, SARS-CoV-2, Zika virus, Chikungunya virus, dengue virus, pepper mild mottle virus, hepatitis A virus, monkeypox virus, and norovirus GII.

There is a growing list of microbes that have been captured and concentrated with the Nanotrap Microbiome Particles. If you don’t see your microbe of interest on this list, let’s connect to discuss your application.

Key Points:​​

Methods developed for clinical swab samples, saliva, urine, wastewater, and blackwater.

Compatible with PCR, sequencing, or immunoassay analysis methods.

Enables rapid and simple automated or manual methods for preparing wastewater samples for nucleic acid extraction, without filtration, centrifugation, or bead-beating.

Successfully utilized in high-complexity and point-of-care RT-PCR assays with FDA Emergency Use Authorization for COVID-19.

Nanotrap® particles utilize affinity capture to attract and bind low abundance microbes. Nanotrap® particles do not utilize antibodies or other biomolecules as affinity molecules which means extended room temperature stability.

For Research Use Only. Not for use in diagnostic procedures.